{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T09:59:39Z","timestamp":1777111179585,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.biopha.2016.08.021","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T17:31:07Z","timestamp":1471714267000},"page":"1141-1145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Interactions between medications employed in treating benign prostatic hyperplasia and food \u2212 A short review"],"prefix":"10.1016","volume":"83","author":[{"given":"Pawe\u0142","family":"Pa\u015bko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Rodacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Domaga\u0142a-Rodacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danuta","family":"Owczarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.08.021_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7897\/2230-8407.04808","article-title":"Benign prostatic hyperplasia: updated review","volume":"4","author":"Praveen","year":"2013","journal-title":"Int. Res. J. Pharm."},{"key":"10.1016\/j.biopha.2016.08.021_bib0010","doi-asserted-by":"crossref","first-page":"g4474","DOI":"10.1136\/bmj.g4474","article-title":"Lower urinary tract symptoms in men","volume":"349","author":"Hollingsworth","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2016.08.021_bib0015","first-page":"10","article-title":"Benign prostatic hyperplasia (BPH) management in the primary care setting","volume":"19","author":"Kapoor","year":"2012","journal-title":"Can. J. Urol."},{"key":"10.1016\/j.biopha.2016.08.021_bib0020","first-page":"1403","article-title":"Diagnosis and management of benign prostatic hyperplasia","volume":"77","author":"Edwards","year":"2008","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.biopha.2016.08.021_bib0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.beem.2008.01.016","article-title":"5\u03b1-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction","volume":"22","author":"Rittmaster","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2016.08.021_bib0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1503\/cmaj.120951","article-title":"Grapefruit-medication interactions: forbidden fruit or avoidable consequences?","volume":"185","author":"Bailey","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.biopha.2016.08.021_bib0035","first-page":"a538","article-title":"Drug Interactions with grapefruit juice","volume":"5","author":"Mazi-Kotwal","year":"2012","journal-title":"BJMP"},{"key":"10.1016\/j.biopha.2016.08.021_bib0040","first-page":"1","article-title":"Benign prostatic hyperplasia: epidemiology, economics and evaluation","volume":"22","author":"Vuichoud","year":"2015","journal-title":"Can. J. Urol."},{"key":"10.1016\/j.biopha.2016.08.021_bib0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/21551197.2012.729902","article-title":"Polypharmacy and food\u2013drug interactions among older persons: a review","volume":"31","author":"Heuberger","year":"2012","journal-title":"J. Nutr. Gerontol. Geriatr."},{"key":"10.1016\/j.biopha.2016.08.021_bib0050","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2165\/00003495-199345030-00008","article-title":"Alfuzosin","volume":"45","author":"Wilde","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2016.08.021_bib0055","unstructured":"Uroxatral (Sanofi-aventis U.S. LLC): Prescribing information."},{"key":"10.1016\/j.biopha.2016.08.021_bib0060","first-page":"80","article-title":"Grapefruit and medications may be a deadly mix- an overview","volume":"3","author":"Deepalakshmi","year":"2014","journal-title":"J. Pharm. BioSci."},{"key":"10.1016\/j.biopha.2016.08.021_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0895-7061(99)00188-0","article-title":"Interaction of alcohol and an \u03b11-blocker on ambulatory blood pressure in patients with essential hypertension","volume":"13","author":"Kawano","year":"2000","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.biopha.2016.08.021_bib0070","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1365-2125.1999.00067.x","article-title":"Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation","volume":"48","author":"Chung","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2016.08.021_bib0075","unstructured":"X.L. Cardura (Pfizer Inc.): Prescribing information."},{"key":"10.1016\/j.biopha.2016.08.021_bib0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF03258458","article-title":"The effects of food on the oral bioavailability of doxazosin in hypertensive subjects","volume":"6","author":"Conway","year":"1993","journal-title":"Drug Invest."},{"key":"10.1016\/j.biopha.2016.08.021_bib0085","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.eursup.2010.04.001","article-title":"Profile of silodosin","volume":"9","author":"Montorsi","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2016.08.021_bib0090","unstructured":"Rapaflo (Actavis Specialty Pharmaceuticals Co): Product monograph."},{"key":"10.1016\/j.biopha.2016.08.021_bib0095","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/13543784.16.12.1955","article-title":"Silodosin, a novel selective \u03b11A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia","volume":"16","author":"Yoshida","year":"2007","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"10.1016\/j.biopha.2016.08.021_bib0100","unstructured":"Flomax (Boehringer Ingelheim Pharmaceuticals, Inc): Prescribing information."},{"key":"10.1016\/j.biopha.2016.08.021_bib0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eursup.2004.11.003","article-title":"Cardiovascular safety of tamsulosin modified release in the fasted and fed state in elderly healthy subjects","volume":"4","author":"Michel","year":"2005","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.biopha.2016.08.021_bib0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eursup.2004.11.002","article-title":"The pharmacokinetic profile of tamsulosin oral controlled absorption system (OCAS\u00ae)","volume":"4","author":"Michel","year":"2005","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.biopha.2016.08.021_bib0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1464-410X.2006.06494.x","article-title":"Pharmacokinetic profile of tamsulosin OCAS","volume":"98","author":"Chapple","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.biopha.2016.08.021_bib0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1067\/mcp.2000.104215","article-title":"Relationship between time after intake of grapefruit juice and the effect on the pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects","volume":"67","author":"Takanaga","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2016.08.021_bib0125","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2125.1991.tb03991.x","article-title":"The influence of food on the oral bioavailability of terazosin","volume":"32","author":"McNeil","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2016.08.021_bib0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2165\/00003088-199630010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of finasteride","volume":"30","author":"Steiner","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biopha.2016.08.021_bib0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-199957010-00014","article-title":"Finasteride","volume":"57","author":"McClellan","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2016.08.021_bib0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11884-009-0014-2","article-title":"Medication and food issues for overactive bladder\/lower urinary tract symptoms: when do we eat?","volume":"4","author":"Maltz","year":"2009","journal-title":"Curr. Bladder Dysfunct. Rep."},{"key":"10.1016\/j.biopha.2016.08.021_bib0145","unstructured":"Avodart (GlaxoSmithKline): Prescribing information."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216306758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216306758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:44:25Z","timestamp":1776944665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216306758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":29,"alternative-id":["S0753332216306758"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.08.021","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between medications employed in treating benign prostatic hyperplasia and food \u2212 A short review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}